Evaluation of Sexual Functions With Validated Measurement Scale After Transvaginal Extraction of Tissue by Laparoscopic Surgery With Uterus Preservation (FSF-TVE)

Launched by UNIVERSITÀ DEGLI STUDI DELL'INSUBRIA · Feb 11, 2019

Keywords

ClinConnect Summary

The clinical trial, called FSF-TVE, is looking at how a specific type of surgery affects women's sexual functions. The surgery involves removing tissue from the uterus using a method that keeps the uterus intact and is done through the vaginal canal. This study is important because, although this technique seems safe and effective, we haven't fully measured how it might impact sexual health. Researchers want to compare the experiences of women who have this surgery with those who have a different method of tissue removal.

To take part in this study, women need to be between the ages of 18 and 62, sexually active, and facing certain benign (non-cancerous) health issues related to the uterus or surrounding areas. However, women with conditions like pelvic inflammatory disease, previous surgeries like a hysterectomy, or other serious health issues won’t qualify. Participants will have the chance to share their experiences regarding sexual function after surgery, helping to provide valuable insights for future patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Benign uterine and adnexal pathology
• • Preservation of the uterus
• • Sexually active women
• • Premenopausal women
• Exclusion Criteria:
• • Pelvic inflammatory disease, endometriosis and pre-existing dyspareunia or chronic pelvic pain of any origin
• • Previous Hysterectomy
• • Other gynecological and non-gynecological (chronic endocrine, metabolic, autoimmune, neoplastic diseases, psychopathology, mental and sensory-motor disabilities) comorbidities
• • Language barrier